Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Interferon-alfa2a in pMMR Colon Cancer
NCT04798612Phase 2Recruiting
- Sponsor
- Zealand University Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in colon cancer, sponsored by Zealand University Hospital. Started Aug 2023; status: recruiting.
02
Drugs
interferon alfa
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04798612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04798612.